List of Excipients in API tedizolid phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tedizolid phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | SIVEXTRO | tedizolid phosphate | 67919-041 | CELLULOSE, MICROCRYSTALLINE | 2030-12-31 |
| Merck Sharp & Dohme LLC | SIVEXTRO | tedizolid phosphate | 67919-041 | CROSPOVIDONE | 2030-12-31 |
| Merck Sharp & Dohme LLC | SIVEXTRO | tedizolid phosphate | 67919-041 | FERRIC OXIDE YELLOW | 2030-12-31 |
| Merck Sharp & Dohme LLC | SIVEXTRO | tedizolid phosphate | 67919-041 | MAGNESIUM STEARATE | 2030-12-31 |
| Merck Sharp & Dohme LLC | SIVEXTRO | tedizolid phosphate | 67919-041 | MANNITOL | 2030-12-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tedizolid phosphate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tedizolid phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
tedizolid phosphate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
tedizolid phosphate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tedizolid phosphate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
tedizolid phosphate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tedizolid phosphate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tedizolid phosphate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
tedizolid phosphate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
tedizolid phosphate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tedizolid phosphate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | tedizolid phosphate | 67919-041 |
| Nabriva Therapeutics US Inc | tedizolid phosphate | 72000-310 |
| >Company | >Ingredient | >NDC |
tedizolid phosphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch